Search

everythinglearnresearchcommunity

for

Search:↓

Leydig cell tumors can cause high testosterone in women and are treated by removing the ovaries.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Chemotherapy can harm kidneys in breast cancer patients.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

Estetrol may help prevent hair loss and support hair growth in women.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

Non-drug treatments like saw palmetto, horsetail, pumpkin seed oil, curcumin, and addressing nutritional deficiencies may help female hair loss.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Total testosterone levels can help diagnose androgen-producing tumors and hyperandrogenism in women.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Frontal Fibrosing Alopecia might be an autoimmune disease.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Menopausal hormone therapy can improve skin and hair health in menopausal women.

The study found that imaging might miss small ovarian tumors causing high testosterone, and suggested using certain testosterone levels and treatment responses to identify these tumors.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Low iron levels are not linked to hair loss in women with androgenetic alopecia.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.